Cepharanthine
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | none |
Identifiers | |
Synonyms | Cepharantin, O-Methylcepharanoline |
PubChem (CID) | 10206 |
ChemSpider | 9791 |
ChEMBL | CHEMBL449782 |
ECHA InfoCard | 100.208.632 |
Chemical and physical data | |
Formula | C37H38N2O6 |
Molar mass | 606.70742 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Cepharanthine is an antiinflammatory and antineoplastic compound isolated from Stephania.[1] Due to these modalities, it has been shown effective against HTLV in lab research. [2] Additionally, it has successfully been used to treat a diverse range of medical conditions, including radiation-induced leukopenia, idiopathic thrombocytopenic purpura, alopecia areata, alopecia pityrodes, venomous snakebites, xerostomia, sarcoidosis, refractory anemia and various cancer-related conditions. No safety issues have been observed with CEP, and side effects are very rarely reported. [3]
References
- ↑ Huang, H.; Hu, G.; Wang, C.; Xu, H.; Chen, X.; Qian, A. (2013). "Cepharanthine, an Alkaloid from Stephania cepharantha Hayata, Inhibits the Inflammatory Response in the RAW264.7 Cell and Mouse Models". Inflammation. 37 (1): 235–46. doi:10.1007/s10753-013-9734-8. PMID 24045962.
- ↑ Synergistic inhibition of HTLV-1-infected cell proliferation by combination of cepharanthine and a tetramethylnaphthalene derivative.
- ↑ Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.